Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Codeine phosphate + promethazine hydrochloride |
Is a |
Product containing codeine phosphate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Codeine phosphate + promethazine hydrochloride |
Is a |
Product containing promethazine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Codeine phosphate + promethazine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Promethazine hydrochloride |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Codeine phosphate + promethazine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Codeine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Codeine phosphate + promethazine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Codeine phosphate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Codeine phosphate + promethazine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Central nervous system agent (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Codeine phosphate + promethazine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Substance with morphinan structure and opioid receptor agonist mechanism of action (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Codeine phosphate + promethazine hydrochloride |
Is a |
Promethazine hydrochloride |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Codeine phosphate + promethazine hydrochloride |
Is a |
Product containing promethazine in oral dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Codeine phosphate + promethazine hydrochloride |
Has manufactured dose form |
Oral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Codeine phosphate + promethazine hydrochloride |
Is a |
Product containing promethazine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|